Antlia Bioscience, Inc.
Encinitas, US · Founded 2020 · Delaware corporation · 5 employees on LinkedIn · 1 known investors
Antlia Bioscience develops long-acting therapeutics aimed at treating chronic cardiometabolic diseases.
Founders & leadership
BL
Brian Laurence JohnsonExecutive
AM
Ankit MahadeviaNamed on SEC filing
Board
BA
Ben AuspitzBoard director
MT
NS
CG
Carlos Garcia EcheverriaBoard director
Investors · 1
Reported raises · per SEC filings
Form D private placements$6.9M disclosed across 3 rounds · 2020–2026
▶$6MraisedJun 2026 · 3 investors · BiotechnologyRule 506(b)
▶$6MraisedJun 2026 · 3 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Ankit MahadeviaExecutive Officer, Director
- Ben AuspitzDirector
- Martin TaylorDirector
- Carlos Garcia EcheverriaDirector
- Nihal SinhaDirector
- Brian Laurence JohnsonExecutive Officer, Director
- Offering amount
- $20M
- Amount sold
- $6M
- First sale
- May 2026
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$680KraisedApr 2022 · 10 investors · Other TechnologyRule 506(b)
▶$680KraisedApr 2022 · 10 investors · Other Technology
Rule 506(b)Officers, directors & promoters on the filing
- Brian Laurence JohnsonExecutive Officer, Director
- Offering amount
- $2.5M
- Amount sold
- $680K
- First sale
- Apr 2022
- Incorporated
- Corporation, Delaware, 2020
- Federal exemptions
- 06b
▶$207KraisedOct 2020 · 7 investors · Other TechnologyRule 506(b)
▶$207KraisedOct 2020 · 7 investors · Other Technology
Rule 506(b)Officers, directors & promoters on the filing
- Brian Laurence JohnsonExecutive Officer, Director
- Offering amount
- $600K
- Amount sold
- $207K
- First sale
- Oct 2020
- Incorporated
- Corporation, Delaware, 2020
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Competitors · 5
by search overlap
Ancilia Bio16 shared keywordsAncilia is a biotech company using CRISPR to create beneficial bacterial products, such as live biotherapeutics, that carry immunity against the viruses that destroy them. It develops computational and biological platforms to identify, characterize, and counter viruses within the microbiome (the virome).
IQVIA14 shared keywordsIQVIA provides data, analytics, AI, and technology-driven services for life sciences and healthcare organizations, spanning clinical development, real world evidence generation, and commercial execution. It offers integrated solutions for clinical trials, regulatory and safety compliance, and market analytics, including agentic AI products for commercial and R&D teams.
Fortis Life Sciences12 shared keywordsFortis Life Sciences develops and manufactures Bethyl-branded ELISA kits and related reagents, buffers, and antibodies for detecting target proteins in research and diagnostic applications. The kits cover human and veterinary targets and are made in the USA using the company's own antibodies.
Intellia Therapeutics8 shared keywordsIntellia Therapeutics develops in vivo and ex vivo CRISPR/Cas9 gene editing therapies aimed at treating the root causes of severe genetic diseases, with lead candidates for hereditary angioedema and ATTR amyloidosis. The company operates as a clinical-stage biopharmaceutical company pursuing potentially curative treatments from discovery through commercialization.
Revalia Bio, Inc.7 shared keywordsRevalia Bio uses AI to convert donated human organs and tissues into multi-modal biological datasets and decision-ready insights for drug and device development. It operates an Organ ICU facility and works with organ procurement organizations and healthcare institutions to serve pharma, biotech, and medical device companies.
Companies competing with Antlia Bioscience, Inc. for the same Google search keywords, organic and paid, via search-intersection analysis.
Frequently asked questions
- What does Antlia Bioscience, Inc. do?
- Antlia Bioscience develops long-acting therapeutics aimed at treating chronic cardiometabolic diseases.
- Who are Antlia Bioscience, Inc.'s investors?
- Antlia Bioscience, Inc.'s investors include F-Prime Capital.
- How much funding has Antlia Bioscience, Inc. raised?
- Antlia Bioscience, Inc. has disclosed $6.9M raised across 3 rounds.
- Where is Antlia Bioscience, Inc. headquartered?
- Antlia Bioscience, Inc. is headquartered in Encinitas, US.